GMP Manufacturing Capabilities

Little Green Pharma has an exclusive agreement with our Manufacturing Partner, a fully licensed TGA GMP-certified pharmaceutical manufacturing company in Western Australia, to manufacture final dose form cannabis medicines on our behalf.

All Little Green Pharma’s medicinal cannabis products are manufactured in accordance with applicable GMP guidelines in facilities audited and licensed by the Therapeutic Goods Administration (TGA). Our Manufacturing Partner’s GMP licensing is recognised by EU regulatory authorities as meeting EU-GMP standards, enabling LGP to import and sell medicinal cannabis products into the EU.

Our Manufacturing Partner is licensed to produce oil, gel cap, suppository, emulsion and spray products, and is anticipated to begin manufacturing dry cannabis flower in late 2020. Little Green Pharma also anticipates introducing new delivery systems into its product range as the market develops.

LGP’s Manufacturing Partner will provide us with sufficient manufacturing capacity to process production from the currently planned cultivation facility expansion and when supplemented by ancillary equipment, the potential 3,000sqm growing space expansion.

Little Green Pharma has also constructed manufacturing facilities capable of being TGA GMP-licensed for extraction activities on its leased premises adjacent to its present cultivation facility. The Company will also seek to enter into product manufacture and supply arrangements to supplement the manufacturing capacity of the Manufacturing Partner if required.